综上，本次交易相关主体不存在依据《上市公司监管指引第 7 号——上 市公司重大资产重组相关股票异常交易监管》第十二条规定的不得参与任何 上市公司重大资产重组的情形。 （以下无正文） （本页无正文，为《华兴证券有限公司关于福建万辰生物科技集团股份有限 公司本次交易相关主体不存在 <上市公司监管指引第7号 上市公司重大资="上市公司重大资"> 产重组相关股票异常交易监管>第十二条情形的核查意见》之签章页） 华兴证券有限公司 关于福建万辰生物科技集团股份有限公司 本次交易相关主体不存在《上市公司监管指引第7号——上市公 司重大资产重组相关股票异常交易监管》 第十二条情形的核查意见 福建万辰生物科技集团股份有限公司（以下简称"公司"或"上市公 司"）拟以支付现金的方式购买淮南市盛裕企业管理有限公司和淮南市会想 企业管理有限公司合计持有的南京万优商业管理有限公司49.00%股权（以下 简称"本次交易"）。根据《上市公司重大资产重组管理办法》相关规定， 本次交易构成重大资产重组。同时，根据《深圳证券交易所创业板股票上市 规则》的相关规定，本次交易构成关联交易。 华兴证券有限公司作为上市公司本次交易的独立财务顾问，就本次交 ...

华兴证券有限公司 关于福建万辰生物科技集团股份有限公司 本次交易产业政策和交易类型的核查意见 福建万辰生物科技集团股份有限公司（以下简称"上市公司"或"公 司"）拟以支付现金的方式购买淮南市盛裕企业管理有限公司（以下简称 "淮南盛裕"）和淮南市会想企业管理有限公司（以下简称"淮南会想"） 合计持有的南京万优商业管理有限公司（以下简称"标的公司"）49.00%股 权（以下简称"本次交易"）。根据《上市公司重大资产重组管理办法》相 关规定，本次交易构成重大资产重组。同时，根据《深圳证券交易所创业板 股票上市规则》的相关规定，本次交易构成关联交易。 华兴证券有限公司（以下简称"独立财务顾问"）作为上市公司本次交 易的独立财务顾问，根据《深圳证券交易所上市公司自律监管指引第8号—— 重大资产重组》《监管规则适用指引——上市类第 1 号》等相关法律法规的 要求，对本次交易产业政策和交易类型进行了专项核查，并发表如下核查意 见： 一、本次交易涉及的行业或企业是否属于《监管规则适用指引——上市类第 农业产业化龙头企业、高档数控机床和机器人、航空航天装备、海洋工程装 备及高技术船舶、先进轨道交通装备、电力装备、新一代信息技术 ...

华兴证券有限公司 关于福建万辰生物科技集团股份有限公司本次交易 符合《创业板上市公司持续监管办法（试行）》第十八条 和《深圳证券交易所上市公司重大资产重组审核规则》 第八条规定的核查意见 福建万辰生物科技集团股份有限公司（以下简称"公司"或"上市公司"） 拟以支付现金的方式购买淮南市盛裕企业管理有限公司和淮南市会想企业管理 有限公司合计持有的南京万优商业管理有限公司（以下简称"标的公司"） 相关规定，本次交易构成重大资产重组。同时，根据《深圳证券交易所创业板 股票上市规则》的相关规定，本次交易构成关联交易。 华兴证券有限公司作为上市公司本次交易的独立财务顾问，就本次交易是 否符合《创业板上市公司持续监管办法（试行）》（以下简称"《 《持续监管办法》"） （本页无正文，为《华兴证券有限公司关于福建万辰生物科技集团股份有 限公司本次交易符合 <创业板上市公司持续监管办法 试行="试行"> 第十八条和 <深> 圳证券交易所上市公司重大资产重组审核规则>第八条规定的核查意见》之签章 页） 财务顾问主办人： 沈颖 官玉霞 《持续监管办法》第十八条规定，"上市公司实施重大资产重组或者发行股 份购买资产的，标的资产所属行业 ...

Group 1 - The company, Fujian Wancheng Biotechnology Group Co., Ltd., plans to acquire a 49.00% stake in Nanjing Wanyou Commercial Management Co., Ltd. through a cash payment, constituting a major asset restructuring and related party transaction [2][4] - The independent financial advisor, Huaxing Securities Co., Ltd., conducted a review of the company's stock price fluctuations prior to the announcement of the transaction [2][4] - Over the 20 trading days leading up to the announcement on August 12, 2025, the company's stock price decreased by 0.46%, while the ChiNext Composite Index increased by 8.32% [3][4] Group 2 - The cumulative price fluctuation of the company's stock, after excluding the impact of the broader market and industry indices, was -2.51% over the same period [3][4] - The independent financial advisor concluded that the stock price fluctuations did not exceed 20%, indicating no abnormal volatility prior to the transaction announcement [4]

等廉洁从业风险防控的意见》相关规定的核查意见 福建万辰生物科技集团股份有限公司（以下简称"上市公司"或"公 司"）拟以支付现金的方式购买淮南市盛裕企业管理有限公司和淮南市会想 企业管理有限公司合计持有的南京万优商业管理有限公司 49.00%股权（以下 简称"本次交易"）。根据《上市公司重大资产重组管理办法》相关规定， 本次交易构成重大资产重组。同时，根据《深圳证券交易所创业板股票上市 规则》的相关规定，本次交易构成关联交易。 华兴证券有限公司（以下简称"独立财务顾问"）作为上市公司本次交易 的独立财务顾问，根据《关于加强证券公司在投资银行类业务中聘请第三方等 廉洁从业风险防控的意见》（证监会公告[2018]22 号）相关规定，就独立财务 顾问及上市公司本次交易中有偿聘请第三方机构或个人（以下简称"第三方"） 等相关行为进行核查，并发表如下核查意见： 一、独立财务顾问有偿聘请第三方的核查 在本次交易中，独立财务顾问不存在直接或间接有偿聘请第三方的行为。 二、上市公司有偿聘请第三方的核查 华兴证券有限公司 关于福建万辰生物科技集团股份有限公司本次交易 符合《关于加强证券公司在投资银行类业务中聘请第三方 构。 此外 ...

Meeting Information - The company plans to hold its third extraordinary general meeting of shareholders on August 27, 2025, at 15:00 [1] - The meeting has been approved by the company's fifth board of directors at its sixteenth meeting [1] - Shareholders can vote either in person or via the internet, with specific voting times outlined [1][4] Voting Procedures - Shareholders must choose one voting method (in-person or online) and cannot vote multiple times [1] - The voting will be conducted on non-cumulative proposals, with specific proposals listed for approval [2][4] - The voting process includes a detailed procedure for both the Shenzhen Stock Exchange trading system and the internet voting system [4] Attendance and Registration - All shareholders registered by the equity registration date are entitled to attend the meeting [2] - Registration procedures for individual and corporate shareholders are specified, including necessary documentation [2][3] Proposals for Approval - The meeting will discuss several proposals, including: - A non-public issuance of exchangeable bonds [2] - Acceptance of guarantees from related parties and provision of counter-guarantees [2] - Nomination of a candidate for the supervisory board [2]

Core Viewpoint - Suzhou Ailong Technology Co., Ltd. plans to acquire a factory building from its affiliate, Chuzhou Zhuyi Technology Co., Ltd., for approximately RMB 13.5 million, which is part of a related party transaction [1][2][9]. Summary by Sections 1. Overview of Related Party Transaction - The transaction involves the purchase of a factory located at No. 1, Quanzhou Road, Chuzhou City, Anhui Province, by the company's subsidiary, Yigu Research Institute, for business development needs [2][6]. - The expected transaction price is RMB 13.5 million, funded by the subsidiary's own or self-raised funds [2][6]. 2. Board Approval Process - The transaction has been approved by the company's board and supervisory committee, with related directors abstaining from voting [3][10]. - The transaction does not require shareholder meeting approval as it does not meet the threshold [3][10]. 3. Transaction Counterparty Information - The seller, Chuzhou Zhuyi Technology Co., Ltd., was established on December 22, 2021, with a registered capital of RMB 150 million [4][5]. - The company is involved in real estate development and various management services [4][5]. 4. Asset Details - The factory building has a total area of 8,010.72 square meters and is not subject to any mortgages or legal disputes [6][8]. - The transaction price is based on market rates for similar properties and is deemed fair and reasonable [6][9]. 5. Impact on the Company - The transaction aligns with the company's long-term strategic goals and will not adversely affect its financial status or operational independence [9][10]. - The board and supervisory committee believe the transaction will benefit the subsidiary's sustainable development [10]. 6. Historical Related Transactions - The company previously announced a financing guarantee for Chuzhou Zhuyi Technology, which was approved by shareholders, but no actual guarantees have been provided to date [1][11].

Group 1 - The company plans to engage in a new related party transaction with its controlling shareholder's subsidiary, with an estimated amount of 25 million yuan [1][2] - The transaction involves labor dispatch services provided by a subsidiary of the controlling shareholder, which has been approved by the board and requires further approval from the shareholders' meeting [1][2][7] - The pricing for the transaction is based on market principles and has been determined through negotiation, ensuring fairness and compliance with market pricing standards [4][7] Group 2 - The related party involved, Tibet Tianhui Human Resources Management Development Co., Ltd., is a wholly-owned subsidiary of the controlling shareholder, Tibet Construction and Building Materials Group [2][3] - The financial status of Tianhui Human Resources indicates a solid ability to fulfill its obligations, as it is not listed as a dishonest executor [4][5] - The labor dispatch agreement will include provisions for wages, social insurance, and management fees, with specific payment timelines and conditions outlined [5][6][7]

Core Viewpoint - The financial advisor, Everbright Securities, has conducted a thorough review of the equity change report for Southern Black Sesame Group Co., Ltd, confirming the authenticity, accuracy, and completeness of the disclosed information, and asserting that the equity change aims to enhance the company's management and resource allocation, ultimately improving profitability and market competitiveness [1][5][6]. Summary by Sections 1. Authenticity, Accuracy, and Completeness of Information - The financial advisor has verified that the information provided in the detailed equity change report is true, accurate, and complete, in compliance with relevant laws and regulations [5][6]. - The advisor has not found any false records, misleading statements, or significant omissions in the report [5][6]. 2. Purpose of the Equity Change - The equity change is aimed at gaining control over the listed company, with the intention of leveraging industry resources and management expertise to enhance business development and shareholder returns [6][12]. 3. Future Plans of the Information Disclosure Obligor - There are currently no specific plans for further share increases or disposals within the next 12 months, and any future changes will be disclosed in accordance with legal requirements [6][12]. - The information disclosure obligor supports the stable development of the company's existing business and does not plan any major adjustments to the main business in the next 12 months [17][18]. 4. Financial Status and Business Operations - The information disclosure obligor, Guangxi Travel Health Industry Group Co., Ltd, focuses on three main business sectors: medical services, elderly care, and health food, aiming to become a leader in the regional health industry [12][13]. - Recent financial data indicates a total asset increase from 484,254.56 million yuan in 2023 to 604,096.11 million yuan in 2024, with a net profit of 7,161.21 million yuan in 2024 [13]. 5. Impact on the Listed Company - The equity change will not affect the independence of the listed company, which will maintain its independent legal status and governance structure [22][23]. - The financial advisor has confirmed that there are no substantial competitive overlaps between the businesses of the information disclosure obligor and the listed company, ensuring no significant competition arises from this equity change [22][23]. 6. Compliance and Governance - The information disclosure obligor has adhered to necessary internal approval processes for the equity change, including board meetings and approvals from relevant authorities [17][19]. - The advisor has provided guidance to ensure compliance with market regulations and will oversee the information disclosure obligations related to the equity change [15].

Meeting Overview - The fourth meeting of the Supervisory Board of Tibet Gaozheng Mining Explosives Co., Ltd. was held on August 11, 2025, with all five supervisors present, confirming the legality and validity of the meeting procedures [1]. Resolutions Passed - The Supervisory Board unanimously approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's actual situation without any false statements or omissions [1][2]. - The board approved an estimated new daily related transaction of 18 million yuan with Tibet Zhongjin Xinlian Blasting Engineering Co., Ltd. for the year 2025, based on market pricing principles [2][3]. - The board also approved an estimated new related transaction of 25 million yuan with a subsidiary of the controlling shareholder, Tibet Jian Group, for the year 2025, with the voting process ensuring that related supervisors recused themselves from the decision [3]. Disclosure - The announcements regarding the new related transactions will be published in major financial newspapers and on the official website [2][3].